AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 185 filers reported holding AMYLYX PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,072 | -89.8% | 72,824 | -87.3% | 0.01% | -93.0% |
| Q3 2023 | $10,521 | -4.9% | 574,623 | +12.0% | 0.10% | +11.1% |
| Q2 2023 | $11,067 | -4.2% | 513,091 | +30.3% | 0.09% | -6.2% |
| Q1 2023 | $11,557 | +53.4% | 393,904 | +93.1% | 0.10% | -11.9% |
| Q4 2022 | $7,535 | -99.6% | 203,937 | +227.8% | 0.11% | +373.9% |
| Q3 2022 | $1,751,000 | +468.5% | 62,219 | +288.6% | 0.02% | +475.0% |
| Q2 2022 | $308,000 | – | 16,013 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpha Wave Global, LP | 853,262 | $18,404,861 | 12.06% |
| Stonepine Capital Management, LLC | 1,121,028 | $24,180,574 | 8.72% |
| GREAT POINT PARTNERS LLC | 968,795 | $20,896,908 | 4.09% |
| Ghost Tree Capital, LLC | 550,000 | $11,863,500 | 3.92% |
| Perceptive Advisors | 4,873,919 | $105,130,433 | 3.04% |
| Altium Capital Management LP | 185,000 | $3,990,450 | 3.02% |
| Boxer Capital, LLC | 2,084,000 | $44,952 | 2.08% |
| SECTORAL ASSET MANAGEMENT INC | 387,310 | $8,354,277 | 1.39% |
| AlphaCentric Advisors LLC | 108,000 | $2,329,560 | 1.29% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 680,035 | $14,668,355 | 0.80% |